What Are Protein C and Protein S Tests?

What Are Protein C and Protein S Tests?

Sudden shortness of breath, chest pain, coughing up blood, one sided leg swelling or pain, or sudden weakness, numbness or slurred speech need emergency care, call 911.

This page is educational and not medical advice.

What follows is what this protein does, how the three different assays differ, what a low value can and cannot tell you, and why the timing of the blood draw matters more here than for almost any other marker on a coagulation report.

What does protein S actually do in the bloodstream?

Protein S is a plasma protein, made mainly in the liver, that works as a cofactor for activated protein C, one of the body's built in brakes on clot formation 1. It does not dissolve clots, and it does not stop clotting from happening. Its job is to keep a normal clotting response local and proportionate, so the mesh that seals a damaged vessel does not keep spreading into healthy blood.

Its production depends on vitamin K, and that matters for two practical reasons. Anything that interferes with vitamin K handling, including liver disease and poor vitamin K status, can pull the level down 1. And because the same vitamin K dependent pathway produces several other clotting proteins, this marker rarely moves in isolation, which is why clinicians read it next to the rest of the panel rather than on its own.

The protein also circulates in two separate pools. Roughly 40 percent travels free in plasma, and the remainder is bound to a carrier molecule called C4b binding protein 1. Only the free pool can act as a cofactor for activated protein C. That is why a laboratory can report a perfectly ordinary total value and a low free value in the same tube of blood, and it is the single most common source of confusion when people read these results for the first time.

One more framing point. A result inside the reference range does not rule out a tendency to clot, and a single low result does not establish one. The number is an observation. What it may reflect depends on when the blood was drawn, what else was happening in the body that day, and what the other natural anticoagulants look like alongside it.

How does the protein C system switch clotting off?

The shutdown signal starts with thrombin, the same enzyme that drives clot formation. When thrombin reaches undamaged vessel lining, it binds a surface receptor called thrombomodulin, and that pairing converts protein C into activated protein C. Activated protein C then breaks down two of the amplifying factors in the clotting cascade, factor Va and factor VIIIa, which slows further thrombin production 2.

Protein S is the partner that makes this efficient. Acting as a cofactor, it holds activated protein C in the right place on the cell membrane surface so the inactivating step happens quickly. Without enough functioning cofactor, the brake still exists but it is applied more weakly, and thrombin generation runs longer than it otherwise would.

The pairing explains why these two markers are almost always ordered together. Deficiency of protein C produces a comparable picture of reduced anticoagulant capacity 2, and a third protein, antithrombin, provides a separate brake on the same system. There is also a mirror image problem. In factor V Leiden, the clotting factor itself is altered so that activated protein C cannot inactivate it efficiently, which is described among the inherited thrombophilias alongside the natural anticoagulant deficiencies 3. Different fault, same consequence, a brake that does not bite as hard as it should.

Why does this braking system matter for clot risk?

It matters because venous clots form when the balance between clot promoting and clot limiting forces tips, and the natural anticoagulants are most of the limiting side. Research suggests that inherited deficiencies of the natural anticoagulant proteins are associated with venous thromboembolism, the umbrella term covering deep vein thrombosis and pulmonary embolism 3.

The important nuance is that a deficiency is a risk factor, not a verdict. Many people who carry one never have a clot, and clots very often need a second ingredient such as surgery, immobility, a long journey, pregnancy or a serious illness. That is why a low value is read in the context of personal history and family history rather than as a standalone finding.

It also matters less for day to day decisions than most people assume. Studies indicate that knowing a person carries an inherited thrombophilia rarely changes how an acute clotting episode is managed, because those decisions are driven mainly by whether the event was provoked, by how it behaves, and by bleeding risk 4. The marker is useful information. It is not usually the information that decides the next step on its own, and any management decision belongs to the clinician.

What do the three main assays measure?

Three different numbers can appear on a report, and they are not interchangeable.

Protein S activity, often labelled functional protein S, measures how well the protein performs its cofactor job in a clotting reaction. It gives the most complete picture of function, and it is also the assay most easily disturbed by other substances in the sample.

Free protein S antigen measures how much unbound protein is present, which is the fraction actually available to work. Thrombophilia testing guidance suggests that the free antigen assay is the preferred first line measurement, because it avoids much of the interference that affects clot based activity testing 5.

Total protein S antigen measures everything, the free pool and the carrier bound pool together. On its own, it can look entirely ordinary while the usable free fraction is low.

Read together, those three numbers sort low results into recognised patterns. A quantitative deficiency shows low total antigen, low free antigen and low activity together. A qualitative deficiency shows antigen levels inside the range with reduced activity, because the protein is present but does not function properly. A third pattern shows total antigen inside the range with low free antigen and low activity, where the split between the free and bound pools has shifted rather than the total amount falling short 1. Those distinctions are the reason a clinician may order all three rather than one.

What do typical results look like, and what counts as low?

Results are reported as a percentage of a normal reference plasma rather than as a concentration, and the laboratory that ran the sample sets the cut points. The table below shows how the three assays are typically presented.

Test What it measures Units Typical lab reference range
Protein S activity (functional protein S) How well the protein works as a cofactor for activated protein C % of normal pooled plasma Roughly 60 to 140, set by each laboratory
Free protein S antigen The unbound pool available to act % of normal pooled plasma Roughly 60 to 140, set by each laboratory
Total protein S antigen Free plus carrier bound protein together % of normal pooled plasma Roughly 60 to 140, set by each laboratory

These are typical lab reference ranges, not diagnostic verdicts, and they vary by laboratory, age and sex. Testing guidance notes that reference intervals are often reported separately for men and women, because levels tend to run lower in women and lower again during pregnancy 5. Two laboratories using different assay methods can return different percentages on the same blood, which is why results are compared against the range printed on that specific report and why repeat testing is usually done at the same laboratory.

A value just under the lower limit is best described as suboptimal rather than abnormal in any final sense. Borderline results are common, they drift with circumstances, and they are confirmed on a second sample before anyone draws conclusions from them.

What can a low or high result reflect?

A low result reflects either an inherited deficiency or, far more often, something temporary that has pushed the level down on the day of the draw. The three assay patterns described above help separate those possibilities, and family testing often helps more, because an inherited deficiency tends to show up in first degree relatives while an acquired dip does not 1.

The practical reading goes in three steps. The observation is a percentage below the laboratory's lower limit. What it may reflect is reduced natural anticoagulant capacity, a transient physiological state, an assay interference, or a combination. What is worth doing is discussing the result with a clinician, who decides whether a repeat sample, a wider panel or no further testing at all is the sensible next step.

A high result sits in a different category. There is no recognised disorder of having too much of this protein, and values above the reference limit are not regarded as a problem in the way low values are. Laboratories set the lower boundary because that is the clinically meaningful edge. An unexpectedly high value is most often a reflection of assay variation or of the reference population used to build the range, and it does not point toward excess bleeding.

What can push levels down without an inherited deficiency?

Plenty, which is exactly why interpretation is so timing dependent. An acute clotting episode consumes natural anticoagulants, so a sample drawn during or soon after a clot can read low in a person whose baseline is unremarkable 5.

Pregnancy and the weeks after delivery lower levels, and testing guidance treats results from those periods as difficult to interpret 5. Some hormone containing medicines have the same effect, and guidance accounts for that when deciding when to draw blood 5.

Liver disease reduces production, because the liver is where this protein is made and where vitamin K dependent processing happens 1. Poor vitamin K status does the same thing through a different route.

Inflammation and infection are an underappreciated cause. The carrier protein that binds this marker rises during an inflammatory response, which shifts more of the total pool into the bound form and leaves less free protein available, so free antigen and activity can fall while total antigen stays put 1. A routine test taken a few days after a bad chest infection can therefore read low for reasons that have nothing to do with genetics.

The common thread is that one low number from one unlucky week is not a finding. A confirmed pattern across two well timed samples is.

Why can testing during a clot or on blood thinners mislead?

Because both situations change the thing being measured. During an acute clot, natural anticoagulants are being used up in real time, so a sample taken then can show a deficiency that was never there 5.

Blood thinners complicate it further. Those that work through the vitamin K pathway directly reduce the vitamin K dependent proteins, including this one, so a low value during that period tells you about the medication rather than the person. Other blood thinners interfere with clot based laboratory assays, which can produce results that look falsely reassuring or falsely low. Testing guidance therefore recommends that samples are taken away from the acute episode and away from anticoagulation, with the timing decided by the clinician supervising care 5.

This is not a minor technicality. Studies indicate that inherited thrombophilia testing ordered during a hospital admission is frequently performed at the wrong moment, is often repeated unnecessarily, and seldom changes what happens to the patient during that stay 7. Research suggests that preanalytical conditions and assay choice have a substantial influence on thrombophilia test results, which is why a single abnormal value is confirmed on a second properly timed sample before it is acted on 6.

The takeaway for a reader holding an unexpected result is simple. Ask when the blood was drawn and what else was going on at the time, before asking what the number means. Never stop or change any medication on the basis of a lab value, that decision belongs to a licensed provider.

Do people with low levels notice symptoms?

No. A deficiency of this protein produces no day to day symptoms of its own, no fatigue pattern, no visible sign, nothing a person could feel. What people notice is a clot, if one ever occurs, and the symptoms belong to the clot rather than to the marker.

In the leg, a deep vein thrombosis usually shows as swelling in one calf or thigh, aching or cramping pain, warmth, and sometimes a change in skin colour. In the lungs, a pulmonary embolism typically shows as sudden breathlessness, chest pain that worsens on breathing in, a racing heartbeat, lightheadedness, or coughing up blood. Clots can also appear in less common sites. Any of these need emergency care, call 911.

Reviews of inherited thrombophilia note that these conditions are associated with venous thromboembolism, including events around pregnancy and the period after delivery 3. Severe deficiency presenting in newborns is described in the literature on these proteins and is extremely rare 1.

Because there are no everyday symptoms, searching for symptoms of a deficiency is the wrong frame. The useful questions are whether there is a personal history of an unexplained clot, whether close relatives have had clots at a young age, and whether a clinician thinks the testing would change anything.

How is the sample taken, and what affects accuracy?

Blood is drawn into a citrated tube, the light blue top used for coagulation testing, and the tube needs to be filled to the mark because the ratio of blood to anticoagulant in the tube affects the result. Plasma is separated promptly and is often frozen and sent to a specialist coagulation laboratory, since these assays are not run on every analyser.

Fasting is not usually required, but the surrounding circumstances matter a great deal. Recent illness, recent clotting, pregnancy, recent surgery and current medication all influence what comes back, so the request form normally captures them. Research suggests that differences in assay methods and preanalytical handling account for a meaningful share of variability in thrombophilia test results, which is one reason repeat testing at the same laboratory is preferred 6.

Confirmation is standard practice rather than caution for its own sake. A low value is typically repeated on a fresh sample taken weeks later under stable conditions, and in some situations relatives are tested to see whether the pattern runs in the family 1. Where results are equivocal, a clinician may order the activity, free antigen and total antigen assays together to see which pattern fits.

Which markers are worth running alongside it?

This marker is almost never interpreted alone. The usual companions are the other natural anticoagulants, protein C and antithrombin, because a shortfall in any of them produces a similar reduction in braking capacity.

Genetic markers often sit in the same workup. Factor V Leiden and the prothrombin gene variant are the two inherited changes most commonly included in a thrombophilia panel, and antiphospholipid antibody testing covers an acquired cause that behaves quite differently and is managed differently.

Routine coagulation screens provide context rather than answers. Prothrombin time with INR and activated partial thromboplastin time describe how quickly plasma clots in the test tube, which helps flag vitamin K dependent effects and liver involvement. Liver markers and a full blood count fill in the rest of the picture, since reduced production and inflammatory states are common explanations for a dip in any of the natural anticoagulants.

Which of these are ordered, and in what sequence, is a clinical decision. Running everything at once is rarely the most informative approach, and guidance favours selective testing in people where the answer could realistically matter 5.

Where does Fibrinogen Activity fit in?

Fibrinogen Activity measures the protein that forms the structural mesh of a clot, so it sits on the clot building side of the same balance that the natural anticoagulants restrain. It is a different question from how well the brakes work, which is why the two are read together rather than interchangeably. The typical lab reference range is 200 to 400 mg/dL, and FitScript's optimal range is 200 to 300 mg/dL, an optimization target rather than a diagnostic cut-off. For what this marker is, how it is measured and what a result may reflect, the linked biomarker page covers it in full.

Who does thrombophilia testing actually help?

Fewer people than the popularity of these panels suggests. Studies indicate that thrombophilia testing rarely alters the management of an acute venous clot, because the length and intensity of anticoagulation is driven mainly by whether the event was provoked and by the person's bleeding risk 4.

Research suggests that selective testing in carefully chosen situations is more defensible than testing everyone who has had a clot 8. The situations that tend to prompt consideration include an unprovoked clot at a young age, clots in unusual sites, a strong family history of clotting, and counselling questions around pregnancy or family planning, where the result may inform preventive decisions made by a clinician.

There is a cost to testing people who do not need it. Testing in the inpatient setting is a particular problem, where it is frequently ordered in conditions that make the result uninterpretable 7.

None of that means an abnormal result should be set aside. It means the question of whether to test, and when, deserves as much attention as the number that comes back.

When is it worth talking to a clinician?

Promptly, if a result sits below the laboratory range, and immediately, if there are signs of a clot. Sudden breathlessness, chest pain, coughing up blood, one sided leg swelling or pain, or sudden weakness, numbness or slurred speech need emergency care, call 911.

Outside an emergency, a conversation is worth having in several situations. If a routine panel returned a low value, a clinician can judge whether the timing and circumstances of the draw explain it. If there is a personal history of an unexplained clot or a family history of clots at a young age, a clinician can decide whether a wider workup would change anything. If pregnancy is being planned, that is a reasonable moment to raise it, since the balance shifts in pregnancy and preventive decisions are individualised.

Discuss your results and any next step with a clinician or licensed provider, and never adjust medication on the strength of a lab value. Treatment decisions belong to a licensed provider who has reviewed the full picture. A FitScript membership includes 150+ biomarkers tested per year with interpretation by Atlas, FitScript's AI health advisor, and any treatment decision still belongs to a licensed provider.

Key takeaways

For more on the clotting tests that commonly appear on the same report, the prothrombin time inr test guide explains how clotting time is measured and what the INR number represents.

References

  1. Protein S deficiency. Thrombosis and Haemostasis, 1997.
  2. Protein C Deficiency. Archives of Pathology & Laboratory Medicine, 2019.
  3. Inherited Thrombophilia. Journal of Pharmacy Practice, 2014.
  4. Thrombophilia Testing and Venous Thrombosis. The New England Journal of Medicine, 2017.
  5. Thrombophilia testing: A British Society for Haematology guideline. British Journal of Haematology, 2022.
  6. Thrombophilia Testing - a Systematic Review. Clinical Laboratory, 2023.
  7. Inpatient inherited thrombophilia testing. Journal of Hospital Medicine, 2016.
  8. Thrombophilia Testing in Venous Thromboembolism. The Medical Clinics of North America, 2025.

Common questions

What is a protein S blood test used for?

It measures one of the body's natural anticoagulants, the proteins that limit how far a clot spreads. Clinicians usually order it as part of a wider clotting workup, most often after an unexplained clot or where there is a family history of clots at a young age. It is not a routine screening test, and a clinician decides whether it is worth doing.

What is the difference between protein S activity and protein S antigen?

Activity, sometimes called functional protein S, measures how well the protein does its job in a clotting reaction. Free antigen measures how much unbound protein is available to work, and total antigen measures the free and carrier bound amounts together. They can disagree, because only the free portion is functional, which is why all three are sometimes ordered.

What are the symptoms of protein S deficiency?

The deficiency itself causes no day to day symptoms. What people notice is a clot, if one ever develops, with signs such as swelling and pain in one leg, or sudden breathlessness and chest pain. Those signs need emergency care, call 911.

Can protein S be low without an inherited condition?

Yes, and this is the more common situation. Pregnancy, the weeks after delivery, liver problems, poor vitamin K status, recent infection or inflammation, and a recent clot can all lower the value temporarily. A clinician looks at when the sample was taken before interpreting a low number.

Should the test be done during a clot or while taking medication that affects clotting?

Generally no, because both situations change the result. An active clot uses up natural anticoagulants, and some medication that affects clotting either lowers this protein directly or interferes with the laboratory method. Testing is usually scheduled away from the acute event, with the timing decided by the clinician supervising care.

Does a low protein S result mean I will get a clot?

No. A low value describes reduced natural anticoagulant capacity, not an event that is going to happen. Many people with a confirmed deficiency never have a clot, and clots usually need an additional trigger such as surgery, immobility or illness. Discuss the result with a clinician rather than drawing a conclusion from the number alone.

How is the sample collected, and do I need to fast?

Blood is drawn into a citrated tube, the light blue top used for clotting tests, and the tube must be filled to the mark for an accurate result. Fasting is not usually required. Tell the clinician about recent illness, surgery, pregnancy and any current medication, since all of these affect how the result is read.

Which other tests are usually ordered alongside it?

Protein C and antithrombin are the usual companions, since they are the other natural anticoagulants. Factor V Leiden, the prothrombin gene variant and antiphospholipid antibody testing are often included, along with basic clotting times, liver markers and a full blood count for context. Which ones are ordered is a clinical decision.

Related reading